The ANTROMBOS brand, founded in 1989 (Belgium), from 2466 sister brands and 17477 competing brands. The ANTROMBOS brand is owned by JOHNSON & JOHNSON, a company listed in New York. ANTROMBOS is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
JOHNSON & JOHNSON
(ANTROMBOS)
over 5 years*
USD 152.83